Adam Feuerstein articles over last 30 days

- articles last 30 days - articles per day
Mentioned in this news Places Companies People
2014/12/18 15:23
2014/12/18 15:23
2d
BOSTON ( TheStreet) -- The votes for Best and Worst Biotech CEOs of 2014 are counted. Your chosen selections are... Congrats, guys, congrats. Applause! Applause! Schenkein and Leschly (or as I like...
2014/12/18 15:23
2014/12/18 15:23
Latest videos
2014/12/16 21:22
2014/12/16 21:22
3d
SAN DIEGO (TheStreet) -- An experimental drug from Auspex Pharmaceuticals(ASPX) significantly reduced the incidence of uncontrolled movements in patients with Huntington's disease compared to a...
2014/12/15 17:23
2014/12/15 17:23
4d
The beleaguered prostate cancer vaccine company filed for voluntary federal bankruptcy protection Monday and reached an agreement with holders of $620 million in convertible debt in which the...
2014/12/10 15:22
2014/12/10 15:22
10d
NEW YORK (TheStreet) -- Five of 27 patients with an aggressive and hard-to-treat form of breast cancer responded to treatment with Merck's(MRK) checkpoint inhibitor Keytruda, according to interim...
2014/12/08 23:22
2014/12/08 23:22
11d
SAN FRANCISCO (TheStreet) -- Bluebird Bio(BLUE) has now treated seven beta-thalassemia patients with its experimental, one-time gene therapy. Four of the patients -- all followed for longer than three...
2014/12/08 12:22
2014/12/08 12:22
12d
SAN FRANCISCO (TheStreet) -- While you were (hopefully) enjoying some time off this weekend, I was sitting in a convention center here writing about biotech and drug companies presenting new data on...
2014/12/07 18:22
2014/12/07 18:22
12d
Of the 73 enrolled patients, 45 patients were evaluable for the efficacy analysis presented at the ASH meeting. The results showed that 25 of the 45 patients achieved a tumor shrinkage response to...
2014/12/06 18:22
2014/12/06 18:22
13d
... very excited about these results because the study enrolled highly refractory patients who had failed all current therapies including [Adcetris] and transplant," said Dr. Alise Reicin, a Merck...
2014/12/06 18:22
2014/12/06 18:22
13d
CAR-T therapies are personalized for each patient. The process starts by harvesting T cells from the patient's blood. In a lab, scientists add a chimeric antigen receptor (CAR) to the surface of the T...
2014/12/06 17:22
2014/12/06 17:22
13d
The ASPIRE study was designed in consultation with regulators in the U.S. and Europe, which gives Amgen confidence that the positive results will be sufficient to win European approval. Some investors...
2014/12/06 17:22
2014/12/06 17:22
13d
Updated with new information. The new Adcetris data comes from a phase III study known as AETHERA, which is being presented in full at the American Society of Hematology annual meeting underway here....
2014/12/06 16:22
2014/12/06 16:22
14d
Adcetris is already approved to treat more advanced Hodgkin patients who don't respond to a stem cell transplant or who are not eligible for stem cell transplants. Seattle Genetics estimates there are...
2014/12/05 11:22
2014/12/05 11:22
15d
BOSTON (TheStreet) -- This week's Biotech Stock Mailbag is open for business. Oke M. writes, "Is Aethlon Medical(AEMD) raising money in a similar way to the Lincoln Park Financial vulture financing...
2014/12/02 14:22
2014/12/02 14:22
18d
Avanir shareholders will receive $17 a share in cash from Otsuka, or a 13% premium to the stock's Monday close. Expect to hear some yelping from Avanir shareholders about management not fetching a...
2014/11/24 12:22
2014/11/24 12:22
26d
The deal is a gamble of sorts for Biomarin, which is betting that its experience and expertise in securing approvals for so-called "orphan disease" drugs can help Prosensa win approval for...
2014/11/21 11:22
2014/11/21 11:22
29d
BOSTON ( TheStreet) -- Washington Post business columnist Steven Pearlstein accused me -- falsely -- of working with short-selling hedge funds to manipulate stock prices and force small biotech...
2014/11/21 11:22
2014/11/21 11:22
29d
Cognate BioServices, the privately held manufacturing services company majority owned by Northwest CEO Linda Powers, continues to benefit from its ties to Northwest. In the third quarter, Northwest...
2014/12/18 15:23
2014/12/18 15:23
Latest from Twitter